Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

270 results about "Metal chelation" patented technology

Metal chelation is the process of using a chelating agent to remove metals from the body. Chelating agents bind to metal ions and hold them in harmless suspension until they are excreted. Metal chelation therapy is most often used to remove toxic levels of lead, mercury, and arsenic from the bloodstream and tissues.

High molecular heavy metal chelating flocculant and preparation method thereof

The invention discloses a high molecular heavy metal chelating flocculant and a preparation method thereof. The high molecular heavy metal chelating flocculant is prepared by the following steps of: quaternizing diallyl methylamine and epoxy chloropropane in an organic solvent, and grafting polyethylene polyamine onto molecules by performing epoxy group ring opening with polyethylene polyamine; decolorizing with active carbon, and evaporating and concentrating to obtain a diallyl quaternary ammonium salt monomer solution; polymerizing through a free radical aqueous solution to synthesize a diallyl quaternary ammonium salt polymer; and reacting with carbon bisulfide and sodium hydroxide. The high molecular heavy metal chelating flocculant is characterized in that: each structural unit of ahigh molecular chain is provided with a positive charge and a plurality of strong chelation groups -CSS- with negative charges, so that the defect of non-uniform positive charge distribution of the conventional ampholytic chelating flocculant is avoided, neutralization of negative charges produced in a floc forming process is facilitated, a floc structure is improved, the formation and growth of floc are promoted, the heavy metal ion chelating capability and flocculating settling performance are enhanced, and the size of sediments is reduced.
Owner:HUNAN UNIV OF SCI & TECH

Novel preparation technology of targeting antitumor fusion protein LPO (lipid peroxidation)

The invention discloses a novel preparation technology of targeting antitumor fusion protein (lipid peroxidation). The novel preparation method comprises the steps of building a fusion expression protein which takes the glutathione S-transferase A (TrxA)-His-tag (His6-Tag)-SUMO protease recognition substrate as a protein soluble expression auxiliary fragment and takes LHRH (luteinizing hormone releasing hormone)-PEA (phenylethylamine) trans-cell penetrating peptides-ONC (LPO for short) as a target segment, connecting the two proteins with each other by a correct read frame and carrier positive sequence and converting to enter into expression bacteria, finally building fusion protein which is connected with six expression substances in series, crudely extracting, carrying out metal chelating medium purification in the presence of imidazole, and carrying out SUMO protease digestion. Compared with the LPO prepared by a conventional method, the LPO prepared by the novel preparation technology disclosed by the invention can obviously improve the inhibiting effect on the tumor cell lines such as colon cancer HT-29 cells, ovarian cancer OVCAR3 cells, cervical adenocarcinoma HeLa cells and liver cancer HepG-2 cells.
Owner:MILITARY VETERINARY RES INST PLA MILITARY MEDICAL ACAD OF SCI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products